Journal of Cardiac Failure
Volume 13, Issue 8 , Pages 618-625 , October 2007

A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure

Received 26 February 2007 ,Revised 27 April 2007 ,Accepted 4 May 2007.

References 

  1. American Heart Association. 2004 Heart Disease and Stroke Statistical update. Available at: http://www.americanheart.org/statistics. Accessed October 17, 2005.
  2. Rohde LE, Clausell N, Ribeiro JP, Goldraich L, Netto R, William Dec G, et al. Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States. Intern J Cardiol. 2005;102:71–77
  3. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1990;66:1348–1354
  4. Stevenson W, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 1995;26:1417–1423
  5. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;18:635–641
  6. Berger R, Huelsman M, Strecker K, Bolic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392–2397
  7. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884–888
  8. Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM, et al. Clinical, radiographic and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90:353–359
  9. Rohde LE, Silva Neto LB, Goldraich L, Grazziotin TC, Palombini DV, Polanczyk CA, et al. Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol. 2004;20:697–702
  10. Stein JH, Neumann A, Preston LM, Costanzo MR, Parrillo JE, Johnson MR, et al. Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. J Am Coll Cardiol. 1997;30:1765–1772
  11. Nagueh SF. Noninvasive evaluation of hemodynamics by Doppler echocardiography. Curr Opin Cardiol. 1999;14:217–224
  12. Schiller NB. Two-dimensional echocardiographic determination of ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation. 1991;84:1280–1287
  13. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66:493–496
  14. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2005. Available at: http://www.acc.org/clinical/guidelines/failure/hf_index.htlm. Accessed October 17, 2005.
  15. Revisão da II Diretrizes da Sociedade Brasileira de Cardiologia para Diagnóstico e Tratamento da Insuficiência Cardíaca. Arq Bras Cardiol. 2002;79(Suppl IV):1–30
  16. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J. 2005;26:1115–1140
  17. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class. Advantages of a new specific activity scale. Circulation. 1981;64:1227–1234
  18. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106–1107
  19. Taylor AL, Ziesche S, Yancy C, Carsib P, D'Agostino R, Ferdinand K, et al. African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049–2057
  20. Hamilton MA, Stevenson LW, Child JS, Moriguchi JD, Walden J, Woo M. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol. 1991;67:259–263
  21. Stevenson LW, Brunken RC, Belil D, Grover-McKay M, Schwaiger M, Schelbert HR, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol. 1990;15:174–180
  22. Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74:1303–1308
  23. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625–1633
  24. Cleland JG, Coletta AP, Feemantle N, Velavan P, Tin L, Clark AL. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail. 2005;7:931–936
  25. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126–1129
  26. Meyer T, Schwaab B, Gorge G, Scharhag J, Herrmann M, Kindermann W. Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure?. Z Kardiol. 2004;93:540–545
  27. Luther SA, McCullough PA, Havranek EP, Rumsfeld JS, Jones PG, Heidenreich PA, et al. for the Cardiovascular Outcomes Research Consortium. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005;11:414–421
  28. Braunschweig F, Fahrleitner-Pammer A, Mangiavacchi M, Ghio S, Fotuhi P, Hoppe UC, et al. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure. Eur J Heart Fail. 2006;8:797–803Epub 2006 May 22
  29. Beck-da Silva L, de Bold A, Fraser M, Williams K, Haddad H. BNP-guided therapy not better than expert's clinical assessment for beta-blocker titration in patients with heart failure. Congest Heart Fail. 2005;11:248–253
  30. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure. Part 2: treatment. Eur Heart J. 2003;24:464–474

 Supported in part by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo a Pesquisa do Rio Grande do Sul and Fundo de Incentivo a Pesquisa.Conflict of Interest Disclosures: No listed authors have any potential conflict of interest with ultrasound equipment industries or manufacturers.All coauthors contributed to the study design and preparation of the final article.

PII: S1071-9164(07)00165-0

doi: 10.1016/j.cardfail.2007.05.003

Journal of Cardiac Failure
Volume 13, Issue 8 , Pages 618-625 , October 2007

Article Tools

* Image Usage & Resolution